8,533 Shares in The Clorox Company (NYSE:CLX) Acquired by Pacific Point Advisors LLC

Pacific Point Advisors LLC acquired a new position in The Clorox Company (NYSE:CLX - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor acquired 8,533 shares of the company's stock, valued at approximately $1,265,000.

Other hedge funds have also recently added to or reduced their stakes in the company. Redwood Park Advisors LLC acquired a new position in shares of Clorox in the fourth quarter worth about $26,000. Millstone Evans Group LLC acquired a new position in Clorox in the 4th quarter worth about $31,000. Asset Planning Inc purchased a new position in Clorox during the fourth quarter worth approximately $32,000. GKV Capital Management Co. Inc. acquired a new stake in Clorox in the fourth quarter valued at approximately $32,000. Finally, Aster Capital Management DIFC Ltd acquired a new stake in Clorox in the fourth quarter valued at approximately $33,000. 78.53% of the stock is owned by hedge funds and other institutional investors.

Insider Activity at Clorox

In other news, Director Pierre R. Breber purchased 4,000 shares of the firm's stock in a transaction on Wednesday, May 7th. The shares were bought at an average cost of $136.57 per share, for a total transaction of $546,280.00. Following the completion of the purchase, the director now directly owns 4,000 shares of the company's stock, valued at approximately $546,280. This trade represents a ∞ increase in their ownership of the stock. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. 0.57% of the stock is owned by insiders.

Clorox Trading Up 0.1%

NYSE:CLX traded up $0.14 on Wednesday, reaching $130.50. The company's stock had a trading volume of 504,004 shares, compared to its average volume of 1,334,148. The Clorox Company has a 12-month low of $127.60 and a 12-month high of $171.37. The stock has a 50 day moving average price of $139.05 and a 200 day moving average price of $151.85. The firm has a market cap of $16.08 billion, a price-to-earnings ratio of 35.67, a price-to-earnings-growth ratio of 2.62 and a beta of 0.60. The company has a quick ratio of 0.60, a current ratio of 0.94 and a debt-to-equity ratio of 20.52.

Clorox (NYSE:CLX - Get Free Report) last posted its earnings results on Monday, May 5th. The company reported $1.45 EPS for the quarter, missing analysts' consensus estimates of $1.57 by ($0.12). Clorox had a net margin of 6.38% and a return on equity of 316.87%. The company had revenue of $1.67 billion during the quarter, compared to analyst estimates of $1.74 billion. During the same period in the previous year, the company earned $1.71 EPS. The company's quarterly revenue was down 8.0% compared to the same quarter last year. On average, equities analysts anticipate that The Clorox Company will post 7.15 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities research analysts recently commented on the stock. Evercore ISI set a $140.00 price target on shares of Clorox and gave the stock an "underperform" rating in a report on Tuesday, May 6th. JPMorgan Chase & Co. decreased their target price on Clorox from $151.00 to $144.00 and set a "neutral" rating on the stock in a research report on Tuesday, May 6th. Barclays lowered their price target on Clorox from $134.00 to $129.00 and set an "underweight" rating on the stock in a research note on Wednesday, May 7th. DA Davidson reduced their price objective on Clorox from $171.00 to $169.00 and set a "neutral" rating for the company in a research note on Wednesday, February 5th. Finally, Citigroup decreased their price objective on Clorox from $165.00 to $150.00 and set a "neutral" rating on the stock in a report on Monday, April 14th. Three research analysts have rated the stock with a sell rating, eleven have given a hold rating and one has given a buy rating to the company. Based on data from MarketBeat, Clorox currently has a consensus rating of "Hold" and an average price target of $151.23.

Clorox Company Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.